Wells Fargo lowered the firm’s price target on MetLife (MET) to $95 from $97 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q2 report. MetLife’s quarter was held back by weak disability and voluntary, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET: